Skip to main content

Table 3 Results of sensitivity analysis of the association between AA/AD and FQ use

From: Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: a nested case–control study

 

Case

Controls

Crude OR

Adjusted OR*

N

%

N

%

OR

95% CI

OR

95% CI

Sensitivity analysis

Nonusers

15,294

71.0

67,570

78.5

1

1

Users

6234

29.0

18,542

21.5

1.51**

1.46–1.56

1.10**

1.06–1.14

  1. Cases that received laboratory tests specific for AA/AD within 28 days prior to the initial diagnosis of AA/AD and their matched controls were included
  2. *Adjusted for covariates presented in Table 1 (sex, age, underlying disease, Charlson comorbidity index, medication use, history of procedure/surgery)
  3. **p < 0.05